Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | NVS | MRK | ||
| Company | Novo Nordisk A/S ADR | Novartis Ag ADR | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 59.91 | 143.78 | 110.71 | ||
| High | 62.40 | 144.76 | 110.73 | ||
| Low | 59.24 | 142.89 | 108.43 | ||
| Latest | 62.33 | 144.34 | 108.83 | ||
| Change | +5.21 | +1.19 | -2.14 | ||
| % Change | +9.12% | +0.83% | -1.93% | ||
| Volume | 43,376,900 | 1,651,500 | 14,852,000 | ||
| 20-Day Average Volume | 21,796,141 | 1,406,515 | 13,517,690 | ||
| Previous Close | 57.12 | 143.15 | 110.97 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.41 | 140.10 | 107.19 | ||
| 20-Day Raw Stochastic | 99.53% | 82.57% | 71.01% | ||
| 20-Day Relative Strength | 69.41 | 65.90 | 61.62 | ||
| Weighted Alpha | +3.38 | +47.79 | +24.80 | ||
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.99% since 01/09/26 | +1.98% since 01/09/26 | -1.54% since 01/09/26 | ||
| Low | 56.29 on 01/15/26 | 140.30 on 01/12/26 | 107.22 on 01/13/26 | ||
| High | 62.40 on 01/16/26 | 146.35 on 01/14/26 | 111.58 on 01/15/26 | ||
| 1-Month | |||||
| %Chg | +27.31% since 12/16/25 | +6.89% since 12/16/25 | +10.75% since 12/16/25 | ||
| Low | 47.51 on 12/18/25 | 134.82 on 12/19/25 | 98.06 on 12/17/25 | ||
| High | 62.40 on 01/16/26 | 146.35 on 01/14/26 | 112.90 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +11.12% since 10/16/25 | +10.38% since 10/16/25 | +29.68% since 10/16/25 | ||
| Low | 43.08 on 11/24/25 | 121.57 on 10/29/25 | 82.01 on 11/04/25 | ||
| High | 62.40 on 01/16/26 | 146.35 on 01/14/26 | 112.90 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | -7.03% since 07/16/25 | +21.94% since 07/16/25 | +32.03% since 07/16/25 | ||
| Low | 43.08 on 11/24/25 | 112.34 on 08/01/25 | 76.66 on 07/29/25 | ||
| High | 71.79 on 07/25/25 | 146.35 on 01/14/26 | 112.90 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 278,303,456 | 304,907,008 | 270,118,560 | ||
| Shares Outstanding, K | 4,465,000 | 2,112,422 | 2,482,023 | ||
| Annual Sales | 42,108,430,000 | 51,722,000,000 | 64,168,000,000 | ||
| Annual Net Income | 14,643,260,000 | 11,941,000,000 | 17,117,000,000 | ||
| Last Quarter Sales | 11,741,240,000 | 14,358,000,000 | 17,276,000,000 | ||
| Last Quarter Net Income | 3,132,940,000 | 3,928,000,000 | 5,785,000,000 | ||
| 60-Month Beta | 0.66 | 0.51 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.02 on 11/05/25 | 2.25 on 10/28/25 | 2.58 on 10/30/25 | ||
| Latest Earnings Date | 02/04/26 | 02/04/26 | 02/03/26 | ||
| Most Recent Dividend | 0.412 on 08/18/25 | 2.596 on 03/12/25 | 0.850 on 12/15/25 | ||
| Next Ex-Dividends Date | 08/18/25 | 03/12/25 | 12/15/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 14.95 | 16.03 | 12.83 | ||